A panel of three proteins (component C7, insulin-like growth factor acid labile subunit, and transgelin 2) accurately categorizes 90% of patients with NAFLD or NASH F3/F4, achieving an AUROC of 0.91. Here, TAGLN2 is linked to metabolic dysfunction-associated steatohepatitis.